[Form 4] Parker-Hannifin Corporation Insider Trading Activity

Rhea-AI Filing Summary

Parker-Hannifin officer Mark T. Czaja received a Stock Appreciation Rights (SAR) award for 3,232 shares on 08/20/2025. The SARs have a grant reference value of $742.97 and were reported as an acquisition. The award becomes exercisable in three equal annual installments beginning 08/20/2026 and expires on 08/19/2035. Following the reported grant, Mr. Czaja is shown as the direct beneficial owner of 3,232 underlying common shares tied to the SARs. The Form 4 was filed by one reporting person and signed by an attorney-in-fact.

Insights

Compensation & Equity Analyst

TL;DR: A mid-level executive SAR grant of 3,232 shares vests over three years; routine compensation, limited immediate dilution.

The grant of Stock Appreciation Rights to the VP-Chief Technology & Innovation is a standard long-term incentive aligning the executive with shareholder value appreciation. The SARs are exercisable beginning one year after grant in three equal annual installments, which staggers potential dilution and retention incentives. The grant’s grant-price reference of $742.97 indicates the base for appreciation, and the reported amount of 3,232 underlying shares represents the maximum common shares deliverable on exercise. This disclosure appears routine and nondilutive in the near term absent immediate exercise.

Corporate Governance Specialist

TL;DR: Filing documents a typical officer equity award with standard vesting and a long expiration; disclosure is complete for Form 4 purposes.

The Form 4 provides required details: transaction date, award type, number of SARs, exercisability schedule, expiration, and direct beneficial ownership after the grant. The use of an attorney-in-fact signature is properly noted. There are no indications of related-party transactions, amendments, or accelerated vesting reported. For governance assessment, this appears as routine compensation disclosure without material governance concerns disclosed in the form.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Czaja Mark T

(Last) (First) (Middle)

6035 PARKLAND BOULEVARD

(Street)

CLEVELAND OH 44124

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Parker-Hannifin Corp [ PH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP-Chief Tech&Innovation Off.

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Appreciation Rights	$742.97	08/20/2025		A		3,232		08/20/2026(1)	08/19/2035	Common Stock	3,232	$0	3,232	D

Explanation of Responses:

1. The Stock Appreciation Rights award vests in three equal annual installments beginning 8/20/26.

	/s/Stephanie R. Breitenbach, Attorney-in-Fact	08/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Parker-Hannifin (PH) report on this Form 4?

The company reported that officer Mark T. Czaja was granted 3,232 Stock Appreciation Rights on 08/20/2025.

When do the SARs become exercisable and when do they expire?

The SARs vest in three equal installments beginning 08/20/2026 and the awards expire on 08/19/2035.

How many shares is Mr. Czaja shown to beneficially own after the grant?

The Form 4 reports Mr. Czaja as the direct beneficial owner of 3,232 shares underlying the SARs following the grant.

What is the reference price listed for the SARs?

The SARs list a reference price of $742.97 in the filing.

Was this Form 4 filed jointly or by a single reporting person?

The Form 4 was filed by one reporting person and signed by an attorney-in-fact on behalf of the reporting person.